Deep Learning in Neurodegenerative Disease Diagnostics

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".

Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 8891

Special Issue Editors


E-Mail Website
Guest Editor
Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Via E Orabona 4, I-70125 Bari, Italy
Interests: complex networks; brain connectivity; biomedical signal processing; magnetic resonance imaging; machine learning
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Via Orabona 4, 70123 Bari, Italy
Interests: machine learning; deep learning; DTI; MRI; alzheimer; connectivity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, we have experienced an exponential growth of artificial intelligence-based applications in many diagnostic fields. In particular, several deep-learning-based algorithms have been refined to extract patterns in high-dimensional clinical and diagnostic imaging datasets, study the relationships between numerous variables, and identify robust biomarkers for a rising number of brain diseases. These techniques have proved particularly effective for studying neurodegenerative diseases, showing promise for early diagnosis, personalized staging, and the development of new therapeutic approaches. However, the successful application of these algorithms in the diagnostic domain requires addressing several issues such as the integration and harmonization of high-dimensional datasets, the robust validation of the performance of the algorithms, the generalization of the techniques developed by using different datasets, and the clinical interpretability of the decisions taken by the algorithms. In this Special Issue, we will collect recent advances based on machine learning and deep learning techniques for the diagnosis of neurodegenerative diseases with imaging, genetic, and clinical data. We encourage work and techniques that aim to strengthen the use of algorithms in diagnostic practice.

Potential topics include but are not limited to the following:

  • Machine learning/deep learning algorithms for classification and diagnosis of neurodegenerative diseases;
  • Machine learning/deep learning models for subtyping neurodegenerative diseases;
  • Harmonization techniques for machine/deep learning;
  • Feature selection;
  • Multimodal data integration for machine/deep learning models;
  • Explainability of machine/deep learning models;
  • Transfer learning on large datasets;
  • Performance optimization.

Dr. Angela Lombardi
Dr. Domenico Diacono
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Diagnosis
  • Machine learning
  • Deep learning
  • Medical imaging
  • Genetics
  • Explainability
  • Alzheimer’s disease
  • Mild cognitive impairment (MCI)
  • Neurodegenerative diseases

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

16 pages, 14892 KiB  
Article
Multi-Focus Image Fusion Based on Convolution Neural Network for Parkinson’s Disease Image Classification
by Yin Dai, Yumeng Song, Weibin Liu, Wenhe Bai, Yifan Gao, Xinyang Dong and Wenbo Lv
Diagnostics 2021, 11(12), 2379; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics11122379 - 17 Dec 2021
Cited by 9 | Viewed by 2708
Abstract
Parkinson’s disease (PD) is a common neurodegenerative disease that has a significant impact on people’s lives. Early diagnosis is imperative since proper treatment stops the disease’s progression. With the rapid development of CAD techniques, there have been numerous applications of computer-aided diagnostic (CAD) [...] Read more.
Parkinson’s disease (PD) is a common neurodegenerative disease that has a significant impact on people’s lives. Early diagnosis is imperative since proper treatment stops the disease’s progression. With the rapid development of CAD techniques, there have been numerous applications of computer-aided diagnostic (CAD) techniques in the diagnosis of PD. In recent years, image fusion has been applied in various fields and is valuable in medical diagnosis. This paper mainly adopts a multi-focus image fusion method primarily based on deep convolutional neural networks to fuse magnetic resonance images (MRI) and positron emission tomography (PET) neural photographs into multi-modal images. Additionally, the study selected Alexnet, Densenet, ResNeSt, and Efficientnet neural networks to classify the single-modal MRI dataset and the multi-modal dataset. The test accuracy rates of the single-modal MRI dataset are 83.31%, 87.76%, 86.37%, and 86.44% on the Alexnet, Densenet, ResNeSt, and Efficientnet, respectively. Moreover, the test accuracy rates of the multi-modal fusion dataset on the Alexnet, Densenet, ResNeSt, and Efficientnet are 90.52%, 97.19%, 94.15%, and 93.39%. As per all four networks discussed above, it can be concluded that the test results for the multi-modal dataset are better than those for the single-modal MRI dataset. The experimental results showed that the multi-focus image fusion method according to deep learning can enhance the accuracy of PD image classification. Full article
(This article belongs to the Special Issue Deep Learning in Neurodegenerative Disease Diagnostics)
Show Figures

Figure 1

Review

Jump to: Research

47 pages, 15751 KiB  
Review
Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson’s Disease Affected by COVID-19: A Narrative Review
by Jasjit S. Suri, Mahesh A. Maindarkar, Sudip Paul, Puneet Ahluwalia, Mrinalini Bhagawati, Luca Saba, Gavino Faa, Sanjay Saxena, Inder M. Singh, Paramjit S. Chadha, Monika Turk, Amer Johri, Narendra N. Khanna, Klaudija Viskovic, Sofia Mavrogeni, John R. Laird, Martin Miner, David W. Sobel, Antonella Balestrieri, Petros P. Sfikakis, George Tsoulfas, Athanase D. Protogerou, Durga Prasanna Misra, Vikas Agarwal, George D. Kitas, Raghu Kolluri, Jagjit S. Teji, Mustafa Al-Maini, Surinder K. Dhanjil, Meyypan Sockalingam, Ajit Saxena, Aditya Sharma, Vijay Rathore, Mostafa Fatemi, Azra Alizad, Padukode R. Krishnan, Tomaz Omerzu, Subbaram Naidu, Andrew Nicolaides, Kosmas I. Paraskevas, Mannudeep Kalra, Zoltán Ruzsa and Mostafa M. Foudaadd Show full author list remove Hide full author list
Diagnostics 2022, 12(7), 1543; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12071543 - 24 Jun 2022
Cited by 7 | Viewed by 4906
Abstract
Background and Motivation: Parkinson’s disease (PD) is one of the most serious, non-curable, and expensive to treat. Recently, machine learning (ML) has shown to be able to predict cardiovascular/stroke risk in PD patients. The presence of COVID-19 causes the ML systems to [...] Read more.
Background and Motivation: Parkinson’s disease (PD) is one of the most serious, non-curable, and expensive to treat. Recently, machine learning (ML) has shown to be able to predict cardiovascular/stroke risk in PD patients. The presence of COVID-19 causes the ML systems to become severely non-linear and poses challenges in cardiovascular/stroke risk stratification. Further, due to comorbidity, sample size constraints, and poor scientific and clinical validation techniques, there have been no well-explained ML paradigms. Deep neural networks are powerful learning machines that generalize non-linear conditions. This study presents a novel investigation of deep learning (DL) solutions for CVD/stroke risk prediction in PD patients affected by the COVID-19 framework. Method: The PRISMA search strategy was used for the selection of 292 studies closely associated with the effect of PD on CVD risk in the COVID-19 framework. We study the hypothesis that PD in the presence of COVID-19 can cause more harm to the heart and brain than in non-COVID-19 conditions. COVID-19 lung damage severity can be used as a covariate during DL training model designs. We, therefore, propose a DL model for the estimation of, (i) COVID-19 lesions in computed tomography (CT) scans and (ii) combining the covariates of PD, COVID-19 lesions, office and laboratory arterial atherosclerotic image-based biomarkers, and medicine usage for the PD patients for the design of DL point-based models for CVD/stroke risk stratification. Results: We validated the feasibility of CVD/stroke risk stratification in PD patients in the presence of a COVID-19 environment and this was also verified. DL architectures like long short-term memory (LSTM), and recurrent neural network (RNN) were studied for CVD/stroke risk stratification showing powerful designs. Lastly, we examined the artificial intelligence bias and provided recommendations for early detection of CVD/stroke in PD patients in the presence of COVID-19. Conclusion: The DL is a very powerful tool for predicting CVD/stroke risk in PD patients affected by COVID-19. Full article
(This article belongs to the Special Issue Deep Learning in Neurodegenerative Disease Diagnostics)
Show Figures

Figure 1

Back to TopTop